Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Nihon Trim Co. Ltd. has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 2 actions are distributed across 2 distinct art units, which means each pending matter is being evaluated by a different technical group. The portfolio involves 2 distinct examiners, creating a situation where every pending office action is under the review of a unique examiner.
ANTHOPOLOS, PETER is the busiest examiner for this portfolio, with 1 pending office action. This 1 action is part of the 2 pending office actions currently active for Nihon Trim Co. Ltd. Because there are 2 distinct examiners for 2 pending actions, there is no overlap in examiner assignments. Practitioners must manage 2 separate prosecution tracks, each tailored to the specific art unit and examiner involved. The 2 distinct art units suggest that the Biotechnology & Pharmaceuticals subject matter is split between different specialized examination branches.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ANTHOPOLOS, PETER | 1 | 57.4% | +58.8% |
| NGUYEN, JOHN P | 1 | 43.9% | +41.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18730182 | METHOD FOR GROWTH OF AKKERMANSIA MUCINIPHILA COMPRISING ADMINISTERING PLATINUM NANOPARTICLES | ANTHOPOLOS, PETER | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18264815 | HYDROGEN WATER FOR PREVENTION OF ALCOHOLIC HEPATOPATHY | NGUYEN, JOHN P | 29d |
| 18730182 | METHOD FOR GROWTH OF AKKERMANSIA MUCINIPHILA COMPRISING ADMINISTERING PLATINUM NANOPARTICLES | ANTHOPOLOS, PETER | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18730182 | METHOD FOR GROWTH OF AKKERMANSIA MUCINIPHILA COMPRISING ADMINISTERING PLATINUM NANOPARTICLES | ANTHOPOLOS, PETER | 1611 | §102§103§112 | Non-Final OA | — | Pending | Jul 18, 2024 |
| 18264815 | HYDROGEN WATER FOR PREVENTION OF ALCOHOLIC HEPATOPATHY | NGUYEN, JOHN P | 1619 | §103 | Final Rejection | 29d | Pending | Aug 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial